Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 1;4(4):583-585.
doi: 10.1001/jamaoncol.2018.0024.

Recurrence in Resected Gastroenteropancreatic Neuroendocrine Tumors

Simron Singh  1 , David L Chan  1 , Lesley Moody  2 , Ning Liu  3 , Hadas D Fischer  3 , Peter C Austin  2   3 , Eva Segelov  4
Affiliations

Recurrence in Resected Gastroenteropancreatic Neuroendocrine Tumors

Simron Singh et al. JAMA Oncol. .

Abstract

This cohort study examines recurrence outcomes in patients with fully resected gastroenteropancreatic neuroendocrine tumors.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure.
Figure.. Cumulative Incidence of Recurrence in NETs by Primary Site
The number of imaging tests declined over time since neuroendocrine tumor (NET) diagnosis, from 1.04 investigations per 100 patient-days in months 1 to 3 to 0.29 in months 25 to 36, and 0.18 in months 109 to 120.
See this image and copyright information in PMC

References

    1. Dasari A, Shen C, Halperin D, et al. . Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335-1342. - PMC - PubMed
    1. Arnold R, Chen Y-J, Costa F, et al. ; Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society . ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentation. Neuroendocrinology. 2009;90(2):227-233. - PubMed
    1. Pape U-F, Maasberg S, Jann H, et al. . Management of follow-up of neuroendocrine neoplasias. Best Pract Res Clin Endocrinol Metab. 2016;30(1):129-140. - PubMed
    1. Austin PC, Lee DS, Fine JP. Introduction to the analysis of survival data in the presence of competing risks. Circulation. 2016;133(6):601-609. - PMC - PubMed

MeSH terms

Supplementary concepts

LinkOut - more resources